Ronald E Blaylock Net Worth & Insider Trades

Ronald E Blaylock - Director, Pfizer Inc

As of April 29, 2022

What is Ronald E Blaylock's Net Worth?

The current estimated net worth of Pfizer Inc's Director, Ronald E Blaylock, is estimated to be about $10.86M . Ronald E Blaylock owns about 13,000 units of Pfizer Inc common stock. In the last 5 years at Pfizer Inc, Ronald E Blaylock has sold an estimated value of $0 worth.

What is Ronald E Blaylock's Past Insider Trading?

Ronald E Blaylock's largest purchase order was 13,000 units , worth over $501.08K on August 10, 2020. In total, Ronald E Blaylock has made about 9 transactions over 5 years of their time at Pfizer Inc. Ronald E Blaylock usually trades in April, with the busiest year in 2021, 2017 and 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Pfizer Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
A. Bourla 2020 $1,650,000 - $4,897,817 $6,782,951 $5,491,800 $1,367,780 $843,222 $21,033,570
A. Bourla 2019 $1,600,000 - $4,290,956 $6,075,290 $3,630,000 $1,726,448 $606,269 $17,928,963
A. Bourla 2018 $1,400,000 - $2,592,079 $3,954,369 $1,533,000 $0 $375,109 $9,854,557
F. D’Amelio 2020 $1,533,750 - $2,406,437 $3,130,596 $2,470,000 $1,318,297 $517,016 $11,376,096
F. D’Amelio 2019 $1,500,000 - $2,582,446 $3,037,649 $1,820,000 $1,612,163 $523,472 $11,075,730
F. D’Amelio 2018 $1,407,917 - $2,013,091 $2,108,995 $1,310,000 $0 $299,826 $7,139,829
M. Dolsten 2020 $1,433,750 - $2,110,585 $2,608,832 $2,600,000 $928,638 $467,819 $10,149,624
M. Dolsten 2019 $1,400,000 - $2,414,725 $2,531,376 $1,820,000 $987,243 $444,701 $9,598,045
M. Dolsten 2018 $1,306,250 - $2,013,091 $2,108,995 $1,326,000 $0 $315,863 $7,070,199
A. Hwang 2020 $1,142,500 - $1,420,129 $2,087,062 $2,387,800 $405,242 $440,714 $7,883,447
J. Young 2020 $1,285,000 - $1,814,734 $2,087,062 $1,800,000 $1,551,403 $450,994 $8,989,193
J. Young 2019 $1,245,000 - $2,247,004 $2,025,093 $1,675,000 $1,325,847 $441,439 $8,959,383
J. Young 2018 $1,206,250 - $2,013,091 $2,108,995 $1,385,000 $0 $408,379 $7,121,715
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/78003/000007800321000047/proxystatement.htm

What are Pfizer Inc's Past Insider Trades?

Pfizer Inc's most recent insider trade came on June 8, 2022 by Jennifer B Damico who sold 4,218 units worth $227.6K . In the last 19 years, insiders at Pfizer Inc have sold an estimated value of $956.55M and bought an estimated value of $479.03M worth of shares. Insider trading is most common in April, with the busiest year in 2013. The most active traders at the company are Loretta V Cangialosi, Sr. Vice President,  Albert Bourla, Chairman & CEO,  and Rady A Johnson, Executive Vice President .

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1